3rd Quarter - Report

BOCKORNY GROUP, INC. for ABBOTT LABORATORIES

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D drug benefit False Claims Act

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
NICOLE VENABLE —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Food Industry (safety, labeling, etc.) FOO

Infant Nutrition

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
NICOLE VENABLE —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Global health and development U.S.- Korea Free Trade Agreement U.S. Negotiations on Trans Pacific Partnership U.S. Trade with Panama and Colombia

LobbyistCovered position, as disclosed
MELISSA SCHULMAN —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Health Issues HCR

Implementation of the Patient Protection and Affordable Health Care Act

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.